Navigation Links
HeartWare to Present at the 29th Annual J.P. Morgan Healthcare Conference
Date:1/4/2011

FRAMINGHAM, Mass. and SYDNEY, Jan. 4, 2011 /PRNewswire/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to make an investor presentation at the 29th Annual J.P. Morgan Healthcare Conference at 1:30 p.m. Pacific Time on Monday, January 10, 2011. The conference is being held January 10-13, 2011 at the Westin St. Francis in San Francisco.

A live webcast of the Company's presentation at the conference will be available via a link provided at www.heartware.com.  An archived replay of the presentation will also be available shortly after the presentation time for a period of 90 days.

About HeartWare InternationalHeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure.  The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-output circulatory support device (up to 10L/min flow) designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices.  HeartWare has received CE Marking for the HeartWare System in the European Union.  The device is currently the subject of United States clinical trials for two indications: bridge-to-transplant under a continued access protocol and destination therapy.  For additional information, please visit www.heartware.com.

HeartWare International, Inc. is a member of the Russell 2000® and its securities are publicly traded on The NASDAQ Stock Market and the Australian Securities Exchange.For further information:Christopher TaylorHeartWare International, Inc.Email: ctaylor@heartwareinc.comPhone: +1 508 739 0864
'/>"/>

SOURCE HeartWare Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare Files PMA Application for FDA Approval of the HeartWare® Ventricular Assist System for a Bridge-to-Transplant Indication
2. HeartWare International, Inc. Announces Completion of Concurrent Public Offerings of Convertible Senior Notes and Common Stock
3. HeartWare International, Inc. Announces Pricing of Concurrent Public Offerings of Convertible Senior Notes and Common Stock
4. HeartWare International, Inc. Announces Concurrent Public Offerings of Convertible Senior Notes and Common Stock
5. HeartWare to Present at the Canaccord Genuity Cardio/Diabetes & Obesity Conference
6. HeartWare Achieves Primary Endpoint with 92% Success in Pivotal Bridge-to-Transplant Clinical Trial, ADVANCE
7. HeartWare to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
8. HeartWare Bridge-to-Transplant Data Featured as Late Breaking Clinical Trial at American Heart Association Scientific Sessions 2010
9. HeartWare International Reports Third Quarter 2010 Revenues of $13.8 Million; Compared to $7.5 Million in Third Quarter of 2009
10. HeartWare to Report Financial Results for Third Quarter of 2010
11. HeartWare to Present at Lazard Capital Markets Circulatory Assist Device Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , Jan. 18, 2017 The Philadelphia Pediatric Medical ... developing medical devices for children. The Consortium chose ... seed grants of $50,000 each. The devices under ... nerve signals, a hand-operated rapid blood delivery system for emergency ... babies. ...
(Date:1/18/2017)... Jan. 18, 2017  Kratom leaves, from a ... are often used to prepare tea-like beverages and ... million Americans annually to increase alertness, enhance well-being ... for minor aches and pains. PinneyAssociates, review of ... to assist FDA and DEA in determining the ...
(Date:1/18/2017)... de 2017  Hoy, en el Foro Económico Mundial, ... global para avanzar el acceso a la prevención de ... renta baja y baja-media (LICs y LMICs). ... particularmente en países de renta baja y media, donde ... muertes relacionadas con NCD. El objetivo de Access Accelerated, ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... January 18, 2017 , ... A recent video posting of a new fidget ... benefits of fidgeting to relieve stress and anxiety. No one was more surprised ... Pen had just completed a successful Kickstarter campaign raising $67,000 on the popular crowdfunding ...
(Date:1/18/2017)... Baltimore, MD (PRWEB) , ... January 18, 2017 ... ... University of Maryland Fischell Department of Bioengineering are collaborating on a research project ... professor in bioengineering, the project seeks to use nanotechnology to control the disease ...
(Date:1/18/2017)... ... January 18, 2017 , ... A Palm Beach doctor plans to run ... international charity that provides free surgery to poor children suffering from cleft lip and ... I have run to support the efforts of the American Heart Association and the ...
(Date:1/18/2017)... , ... January 18, 2017 , ... At Hallmark Nameplate, ... announce that they have achieved certification to ISO 13485. This certification is another way ... up to date products and services that they need. , The ISO 13485 Certification ...
(Date:1/18/2017)... ... January 18, 2017 , ... The Hear the World Foundation, ... the donation of cochlear implants. In February 2017, the first three children with ... chance of leading an independent life. This engagement builds on the support the ...
Breaking Medicine News(10 mins):